申请人:Burgess Laurence E.
公开号:US08569522B2
公开(公告)日:2013-10-29
Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.
式(I)的化合物:其中A1,A2,W,L,G,R7a,R7b,R8,R9和R10具有规范中给出的含义,是DP2受体调节剂,可用于治疗免疫性疾病。